Share
A myriad of AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health, a podcast by a16z Bio + Health and hosted by Kris Tatiossian and Olivia Webb, dives deep into the heart of biotechnology and healthcare innovation. Join veteran company builders, operators, and investors Vijay Pande, Julie Yoo, Vineeta Agarwala, and Jorge Conde, along with distinguished guests like Mark Cuban, Greg ...
…
continue reading
Manage episode 509948955 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Summary:
This week on The Genetics Podcast, Patrick is joined by Andy Singleton, Program Lead of the Global Parkinson’s Genetics Program (GP2), and Sonya Dumanis, COO of the Coalition for Aligning Science. They discuss the creation of GP2, how the initiative is closing representation gaps in genetics, and building global infrastructure and capacity for research.
Show Notes:
0:00 Intro to The Genetics Podcast
00:59 Welcome to Sonya and Andy
01:50 Aims and overview of the Global Parkinson’s Genetics Program (GP2)
03:15 The Aligning Science Across Parkinson’s (ASAP) initiative and how it led to the creation of GP2
04:37 Gaps in Parkinson’s genetics that inspired the creation of GP2
07:21 Closing the global representation gap in Parkinson’s genetics
08:37 ASAP’s model for long-term resources and adaptive funding
11:18 How GP2 overcame pandemic disruptions and data-sharing challenges to grow global capacity
15:01 Using harmonized data to compare Parkinson’s with other neurological diseases
17:02 Expanding GP2’s scope while keeping Parkinson’s at the core
18:42 Using genetics to guide targeted Parkinson’s therapeutics
21:37 Early biomarkers beyond genetics including proteomics and alpha-synuclein seed amplification assay (SAA) to guide therapy timing
23:01 Adapting GP2 to incorporate new discoveries and build capacity for functional and longitudinal studies
26:54 Insights from GBA variants into gene expression and Parkinson’s risk biology
28:24 How GP2’s open access data can be used to power clinical trials and advance drug development
31:37 Lessons from GP2 on building sustainable global collaboration and capacity that can be applied across disease areas
36:10 Navigating global differences in genetic testing access, regulation, and return of results across the GP2 network
38:29 Building coalitions between philanthropy, nonprofits, and industry to sustain large-scale initiatives
41:09 The story behind the GP2 tattoos and the team spirit that fuels the program
42:23 Closing remarks
Find out more
GP2 (https://gp2.org/)
Please consider rating and reviewing us on your chosen podcast listening platform!
https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link
211 episodes
))
